A Lucrative Proposition

Cipla’s promoters are reportedly considering giving the company to an ambitious leader PE firm Blackstone is also interested, while Bain Capital is in talks to bid with Dr. Reddy’s Cipla is an attractive investment due to its market position, therapeutic range and strong results They are in talks with Torrent Pharma that has been in touch with multiple lenders to secure financing Recently, BPEA EQT and General Atlantic expressed interest in buying a majority stake It dominates branded prescription formulations, trade generics, and consumer healthcare…

You're reading a preview of

Business Today (Digital) - 1 Issue, 29 October 2023

DiscountMags is a licensed distributor (not a publisher) of the above content and Publication through Zinio LLC. Accordingly, we have no editorial control over the Publications. Any opinions, advice, statements, services, offers or other information or content expressed or made available by third parties, including those made in Publications offered on our website, are those of the respective author(s) or publisher(s) and not of DiscountMags. DiscountMags does not guarantee the accuracy, completeness, truthfulness, or usefulness of all or any portion of any publication or any services or offers made by third parties, nor will we be liable for any loss or damage caused by your reliance on information contained in any Publication, or your use of services offered, or your acceptance of any offers made through the Service or the Publications. For content removal requests, please contact Zinio.